DBTX(Delisted)
Decibel TherapeuticsยทNASDAQ
--
--(--)
DBTX Profile
Decibel Therapeutics, Inc.
A clinical-stage biotech company that develops transformative treatments for hearing and balance disorders
1325 Boylston Street, Suite 500, Boston, Massachusetts 02215
--
Decibel Therapeutics, Inc., was incorporated under the laws of the State of Delaware on November 26, 2013 as Hearing, Inc. Their name was changed to Decibel Therapeutics, Inc., on April 24, 2014. They are a clinical-stage biotechnology company dedicated to the discovery and development of translational therapies for hearing and balance disorders, one of the largest areas of unmet need in medicine. They aim to restore and improve hearing and balance through the recovery and regeneration of functional hair cells and non-sensory support cells in the inner ear.
